Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and American Lung Association National Office
Alan Patrick Fields, PhD
Mayo Clinic Jacksonville
Jacksonville
FL
Dr. Fields is generating pre-clinical data to support a clinical trial of a novel compound, autothiomalate (ATM), for the treatment of lung cancer. ATM, which is FDA-approved for rheumatoid arthritis, exhibits anti-cancer activity against non-small cell lung cancer (NSCLC) in preclinical studies.